Leggett & Platt (LEG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, will be held virtually with no physical location.
Shareholders can register online to attend and participate in the meeting.
Proxy materials are available online, with options to request paper or email copies at no charge.
Internet-based delivery of proxy materials is encouraged to reduce costs and environmental impact.
Voting matters and shareholder proposals
Election of eight director nominees is on the agenda.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026 is proposed.
Advisory vote on executive compensation (say-on-pay) will be held.
Approval of amendment and restatement of the Flexible Stock Plan is up for vote.
Other business may be transacted as appropriate.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and all proposals listed.
Director nominees include Angela Barbee, Robert E. Brunner, Mary Campbell, Karl G. Glassman, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah, and Phoebe A. Wood.
Latest events from Leggett & Platt
- $2.5B all-stock acquisition expands global reach and targets $50M in annual synergies.LEG
M&A announcement14 Apr 2026 - Director elections, auditor ratification, and executive pay up for vote at 2026 annual meeting.LEG
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Disciplined restructuring and innovation drive margin improvement and cash flow amid market headwinds.LEG
Investor presentation10 Mar 2026 - 2026 outlook: flat-to-down sales, margin gains, and focus on debt reduction amid weak demand.LEG
Q4 202512 Feb 2026 - Q2 loss driven by $675M impairment, lower sales, and restructuring; dividend cut for deleveraging.LEG
Q2 20242 Feb 2026 - Sales and earnings fell, guidance cut, and restructuring, impairment, and deleveraging continue.LEG
Q3 202418 Jan 2026 - Adjusted EPS up to $0.24 despite 7% sales drop; 2025 outlook and deleveraging focus maintained.LEG
Q1 202527 Dec 2025 - Restructuring and cost actions drive margin gains amid weak demand and a cautious 2025 outlook.LEG
Q4 202423 Dec 2025